Fludarabine

CD40 Deficiency

Paul SzabolcsSmall moleculePhase 2Active

CCC

53/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 38/ 100
Competitive Position: 89/ 100

Competitive context

4 Active assets in the CD40 Deficiency cohort.

Asset / Sponsor	Phase	Rating
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER Paul Szabolcs	Phase 2	CCC
Evomela Paul Szabolcs	Phase 2	CCC
Anti-Thymoglobulin, Rabbit Paul Szabolcs	Phase 2	CCC
Campath Paul Szabolcs	Phase 2	CCC

Same molecule, other indications

Fludarabine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant

BBB

Indicative ·

76 / 100

Fanconi anemiaDormant

BBB

Indicative ·

76 / 100

Recurrent Adult Diffuse Large Cell LymphomaDormant

BBB

Indicative ·

76 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.